Trial intelligence / Profile preview

BDP Nebulisation in Moderate Croup

NCT00938353Phase 3Terminated

Sponsor
Chiesi Farmaceutici S.p.A.
Start
Apr 2010
Primary completion
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of beclomethasone dipropionate in croup, sponsored by Chiesi Farmaceutici S.p.A.. Started Apr 2010; status: terminated.

02

Drugs

beclomethasone dipropionate
03

Conditions

croup

Beyond the preview

Go deeper on NCT00938353.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00938353.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call